Chemical Component Summary

NameCitarinostat
Synonyms2-[(2-chlorophenyl)(phenyl)amino]-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide
Identifiers2-[(2-chlorophenyl)-phenyl-amino]-~{N}-[7-(oxidanylamino)-7-oxidanylidene-heptyl]pyrimidine-5-carboxamide
FormulaC24 H26 Cl N5 O3
Molecular Weight467.948
TypeNON-POLYMER
Isomeric SMILESc1ccc(cc1)N(c2ccccc2Cl)c3ncc(cn3)C(=O)NCCCCCCC(=O)NO
InChIInChI=1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31)
InChIKeyVLIUIBXPEDFJRF-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count59
Chiral Atom Count0
Bond Count61
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB15449 
NameCitarinostat
Groups investigational
DescriptionCitarinostat is under investigation in clinical trial NCT02886065 (A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM).
Synonyms
  • Citarinostat
  • (2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)
Categories
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
CAS number1316215-12-9

Related Resource References

Resource NameReference
Pharos CHEMBL3693786
PubChem 53340426
ChEMBL CHEMBL3693786